On 6th December, 2020, Pune based Serum Institute of India (SII), became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking Emergency Use Authorisation for the Oxford COVID-19 vaccine in India, citing unmet medical needs due to the pandemic and in the interest of the public at large, as per news sources. […]